Bio-Techne Temettü
Temettü kriter kontrolleri 0/6
Bio-Techne is a dividend paying company with a current yield of 0.42%. Next payment date is on 22nd November, 2024 with an ex-dividend date of 8th November, 2024.
Anahtar bilgiler
0.4%
Temettü verimi
0.1%
Geri Alım Getirisi
| Toplam Hissedar Getirisi | 0.6% |
| Gelecekteki Temettü Verimi | 0.4% |
| Temettü Büyümesi | -15.5% |
| Bir sonraki temettü ödeme tarihi | 22 Nov 24 |
| Eski temettü tarihi | 08 Nov 24 |
| Hisse başına temettü | US$0.320 |
| Ödeme oranı | 34% |
Son temettü güncellemeleri
Recent updates
Is Bio-Techne (NASDAQ:TECH) A Risky Investment?
Sep 26
Why Bio-Techne Corporation (NASDAQ:TECH) Could Be Worth Watching
Sep 11Bio-Techne Corporation's (NASDAQ:TECH) Price In Tune With Earnings
Aug 24When Should You Buy Bio-Techne Corporation (NASDAQ:TECH)?
Jun 09Bio-Techne Corporation's (NASDAQ:TECH) Shares Climb 33% But Its Business Is Yet to Catch Up
May 21These 4 Measures Indicate That Bio-Techne (NASDAQ:TECH) Is Using Debt Reasonably Well
Apr 30Bio-Techne Corporation (NASDAQ:TECH) Shares Could Be 32% Above Their Intrinsic Value Estimate
Apr 15Bio-Techne: Secular Growth Opportunities Always Exhibit Financial Excellence
Apr 04We Think Bio-Techne (NASDAQ:TECH) Can Stay On Top Of Its Debt
Jan 17Bio-Techne Corporation (NASDAQ:TECH) Investors Are Less Pessimistic Than Expected
Dec 30Estimating The Intrinsic Value Of Bio-Techne Corporation (NASDAQ:TECH)
Dec 05Is Now An Opportune Moment To Examine Bio-Techne Corporation (NASDAQ:TECH)?
Oct 10Bio-Techne (NASDAQ:TECH) Has A Rock Solid Balance Sheet
Sep 22A Look At The Intrinsic Value Of Bio-Techne Corporation (NASDAQ:TECH)
Sep 01At US$80.80, Is Bio-Techne Corporation (NASDAQ:TECH) Worth Looking At Closely?
Jul 10Does Bio-Techne (NASDAQ:TECH) Have A Healthy Balance Sheet?
Jun 22With EPS Growth And More, Bio-Techne (NASDAQ:TECH) Makes An Interesting Case
Jun 07Bio-Techne Corporation's (NASDAQ:TECH) Intrinsic Value Is Potentially 25% Below Its Share Price
May 23When Should You Buy Bio-Techne Corporation (NASDAQ:TECH)?
Apr 05Bio-Techne (NASDAQ:TECH) Has A Rock Solid Balance Sheet
Mar 21Here's Why We Think Bio-Techne (NASDAQ:TECH) Is Well Worth Watching
Mar 06When Should You Buy Bio-Techne Corporation (NASDAQ:TECH)?
Jan 03We Think Bio-Techne (NASDAQ:TECH) Can Manage Its Debt With Ease
Dec 15Should You Be Adding Bio-Techne (NASDAQ:TECH) To Your Watchlist Today?
Nov 30Estimating The Intrinsic Value Of Bio-Techne Corporation (NASDAQ:TECH)
Nov 17Bio-Techne releases new AVV viral titer assays
Oct 11At US$291, Is Bio-Techne Corporation (NASDAQ:TECH) Worth Looking At Closely?
Sep 26Does Bio-Techne (NASDAQ:TECH) Have A Healthy Balance Sheet?
Sep 12Bio-Techne to seek shareholder approval for 4- for-1 stock split
Sep 01Is Now The Time To Put Bio-Techne (NASDAQ:TECH) On Your Watchlist?
Aug 29Bio-Techne releases Quantist Luminex data analysis software
Aug 18Estimating The Intrinsic Value Of Bio-Techne Corporation (NASDAQ:TECH)
Aug 16Yaklaşan Temettü Ödemesi
Ödemelerde İstikrar ve Büyüme
Temettü verilerini getirme
İstikrarlı Temettü: TECH is not paying a notable dividend for the US market, therefore no need to check if payments are stable.
Büyüyen Temettü: TECH is not paying a notable dividend for the US market, therefore no need to check if payments are increasing.
Piyasaya Karşı Temettü Getirisi
| Bio-Techne Piyasaya Karşı Temettü Getirisi |
|---|
| Segment | Temettü Verimi |
|---|---|
| Şirket (TECH) | 0.4% |
| Pazarın Alt %25'i (US) | 1.5% |
| Pazarın En İyi %25'i (US) | 4.5% |
| Sektör Ortalaması (Life Sciences) | 0.5% |
| Analist tahmini (TECH) (3 yıla kadar) | 0.4% |
Önemli Temettü: TECH's dividend (0.42%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.46%).
Yüksek Temettü: TECH's dividend (0.42%) is low compared to the top 25% of dividend payers in the US market (4.55%).
Hissedarlara Ödenen Kazanç
Kazanç Kapsamı: TECH is not paying a notable dividend for the US market.
Hissedarlara Nakit Ödeme
Nakit Akışı Kapsamı: TECH is not paying a notable dividend for the US market.